Bone Health

Latest News

Challenges of Fracture Risk Assessment in Asian and Black Women
Challenges of Fracture Risk Assessment in Asian and Black Women

March 7th 2024

Differences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.

FDA approval stamp in red | Image credit: chrisdorney - stock.adobe.com
FDA Approves First 2 Denosumab Biosimilars

March 5th 2024

Standardized Total Knee Arthroplasty Pathway Improves Outcomes in Minority Patients

May 5th 2021

Variation in Fracture Risk Estimation Among East Asian Women

March 10th 2021

Economic Burden of Osteoporotic Fractures: The Tip of the Iceberg?

December 11th 2020

More News

Study Identifies Inverse Relationship Between BMD T-Score and Fracture Risk When Treated With Denosumab
April 17th 2019

Study Identifies Inverse Relationship Between BMD T-Score and Fracture Risk When Treated With Denosumab

Jaime Rosenberg
Incidence of nonvertebral fractures significantly decreased as T-scores improved during treatment with denosumab for osteoporosis.
Majority of Older Women in Europe at Risk of Fragility Fractures Not Treated for Osteoporosis
April 13th 2019

Majority of Older Women in Europe at Risk of Fragility Fractures Not Treated for Osteoporosis

Jaime Rosenberg
Study data revealed that 55% of women over age 70 are at risk of fragility fractures, but 75% of these women are not treated for osteoporosis.
FDA Approves New Treatment for Postmenopausal Women With Osteoporosis
April 10th 2019

FDA Approves New Treatment for Postmenopausal Women With Osteoporosis

Laura Joszt, MA
FDA has approved a monoclonal antibody to treat postmenopausal women who have a higher risk of bone fracture.
Older Women Far More Likely Than Older Men to Be Tested, Treated for Osteoporosis
April 5th 2019

Older Women Far More Likely Than Older Men to Be Tested, Treated for Osteoporosis

Laura Joszt, MA
Older men are less likely than older women to have their bone mineral density measured and be prescribed treatment for osteoporosis.
Understanding Which Risk Factors for Osteoporosis Can Change
December 25th 2018

Understanding Which Risk Factors for Osteoporosis Can Change

Allison Inserro
Which risk factors of osteoporosis can be modified, and which cannot? With osteoporosis causing more than 9 million fractures globally, understanding how to prevent it can reduce this growing threat to a rapidly aging population, researchers recently reported.
Use of Testosterone in Men With HIV Is Associated With Higher Bone Mineral Density
December 21st 2018

Use of Testosterone in Men With HIV Is Associated With Higher Bone Mineral Density

David Bai, PharmD
Who Should Take Calcium Supplements?
December 20th 2018

Who Should Take Calcium Supplements?

Allison Inserro
A recent review of calcium supplementation suggests that the supplements should be prescribed with caution, accounting for individual risks and benefits.
Osteoporosis Working Group Creates Recommendations for Economic Evaluations
December 15th 2018

Osteoporosis Working Group Creates Recommendations for Economic Evaluations

Allison Inserro
A working group of osteoporosis experts established recommendations for the design and conduct of economic evaluations in osteoporosis, as well as guidance for reporting these evaluations. The group also created a set of minimum criteria for evaluations and an osteoporosis-specific checklist of items to incorporate in economic reports.
Osteoporosis Screening Strategies Don't Identify Younger Women at Risk
December 15th 2018

Osteoporosis Screening Strategies Don't Identify Younger Women at Risk

Allison Inserro
Current screening for women between ages 50 and 64 for osteoporosis needs improvement, according to a recent comparison of treatment and screening strategies from different organizations in the United States and Canada.
Using Virtual Reality to Help Prevent Falls in the Elderly
December 8th 2018

Using Virtual Reality to Help Prevent Falls in the Elderly

Allison Inserro
Can virtual reality help prevent falls in elderly patients? A small study suggests that it can.
Persistent Osteoporosis Medication Use Is Associated With Less Fracture Risk
December 5th 2018

Persistent Osteoporosis Medication Use Is Associated With Less Fracture Risk

David Bai, PharmD
The use of osteoporosis medication for 12 months reduced the risk of fractures and decreased medical costs in elderly female Medicare beneficiaries with osteoporosis, according to the results of a recent study.
What Are The Factors That Influence Adherence to Medications for Osteoporosis?
November 30th 2018

What Are The Factors That Influence Adherence to Medications for Osteoporosis?

Allison Inserro
Despite the fact that osteoporosis is a growing public health problem in the United States and worldwide, there is poor adherence to medications to treat the problem. A recent study published in Osteoporosis International identified the factors that influence patient adherence to therapy, many of which are modifiable.
Study Examines Link Between Treatment Choice, Osteoporosis, Atrial Fibrillation
November 23rd 2018

Study Examines Link Between Treatment Choice, Osteoporosis, Atrial Fibrillation

Allison Inserro
A population-based study in Taiwan examined whether or not vitamin D or bisphosphonates affect the risk of atrial fibrillation (AF) in postmenopausal women with osteoporosis.
Thyroid-Stimulating Hormone Suppression Does Not Significantly Affect Bone Mineral Density
November 21st 2018

Thyroid-Stimulating Hormone Suppression Does Not Significantly Affect Bone Mineral Density

David Bai, PharmD
No significant differences in bone mineral density (BMD) were observed between patients with differentiated thyroid carcinoma (DTC) who received thyroid-stimulating hormone suppression (TSHS) and those who did not, according to a recent study.
Common Probiotic Stimulates Bone Formation in Mice, Study Says
November 14th 2018

Common Probiotic Stimulates Bone Formation in Mice, Study Says

Allison Inserro
A widely used probiotic, Lactobacillus rhamnosus GG (LGG), stimulated bone formation in mice, according to a recent study.
Denosumab Appears to Help Patients With Transfusion-Dependent Thalassemia, Osteoporosis
November 13th 2018

Denosumab Appears to Help Patients With Transfusion-Dependent Thalassemia, Osteoporosis

David Bai, PharmD
Patients with transfusion-dependent thalassemia (TDT) and osteoporosis who were treated with denosumab had greater increases in bone mineral density in the femoral neck and lumbar spine, as well as lower pain scores and bone resorption biomarkers, compared with placebo, according to the results of a phase 2b trial.
Alendronate for Glucocorticoid-Induced Osteoporosis Does Not Reduce Fracture Risk
November 10th 2018

Alendronate for Glucocorticoid-Induced Osteoporosis Does Not Reduce Fracture Risk

Allison Inserro
A recent review of alendronate for the treatment of glucocorticoid-induced osteoporosis (GIO) found that it significantly increased bone mineral density of the lumbar spine and femoral neck in patients with GIO, but does not appear to reduce the risk of fractures.
Links Seen Between Nonalcoholic Fatty Liver Disease and Increased Bone Loss, Osteoporosis
November 9th 2018

Links Seen Between Nonalcoholic Fatty Liver Disease and Increased Bone Loss, Osteoporosis

David Bai, PharmD
Nonalcoholic fatty liver disease (NAFLD) has many identifiable risk factors and inflammatory biomarkers that are linked to osteoporosis, according to the results of a recent review.
Calcaneal Quantitative Ultrasound May Serve as a Prescreening Tool for Osteoporosis
November 3rd 2018

Calcaneal Quantitative Ultrasound May Serve as a Prescreening Tool for Osteoporosis

David Bai
Calcaneal quantitative ultrasound (QUS) has comparable diagnostic accuracy as dual-energy x-ray absorptiometry (DXA), the gold standard for diagnosing osteoporosis. Although it cannot replace DXA for diagnosing osteoporosis, it can be used as an effective prescreening tool prior to a DXA scan, researchers said it a recent study comparing the performance of the 2 screening methods.
Cataracts Linked to Higher Risk of Osteoporosis, Fracture
October 30th 2018

Cataracts Linked to Higher Risk of Osteoporosis, Fracture

Allison Inserro
A recent study from Taiwan found that having cataracts was independently associated with increased risks of osteoporosis and fracture, and there also might be an association between cataract surgery and lower risks of osteoporosis and fracture.
Comparing Effectiveness of Osteoporosis Drugs on Risk of Fracture in 2 Countries
October 26th 2018

Comparing Effectiveness of Osteoporosis Drugs on Risk of Fracture in 2 Countries

Allison Inserro
Researchers aimed to compare the clinical effectiveness of oral anti-osteoporosis drugs based on the observed risk of fracture while receiving treatment through primary care in the United Kingdom and Spain.
Timing of Low Molecular Weight Heparin Does Not Affect Mortality in Hip Fracture Surgery
October 23rd 2018

Timing of Low Molecular Weight Heparin Does Not Affect Mortality in Hip Fracture Surgery

David Bai, PharmD
Postoperative and preoperative start of low molecular weight heparin (LMWH) does not change the outcome of mortality or risk of reoperation in patients with hip fractures treated with osteosynthesis, according to a recent study.
Selective Estrogen Receptor Modulators Have Higher Reduced Hip Fracture Risk Than Alendronate
October 19th 2018

Selective Estrogen Receptor Modulators Have Higher Reduced Hip Fracture Risk Than Alendronate

David Bai, PharmD
A retrospective cohort study by compared different osteoporosis preventative-medications and found that selective estrogen receptor modulators (SERM) had better hip and major fracture risk reductions than alendronate, while strontium ranelate (SR) had poorer hip and major fracture risk reduction than alendronate.
Large Review Finds Vitamin D Ineffective in Preventing Fractures, Falls
October 16th 2018

Large Review Finds Vitamin D Ineffective in Preventing Fractures, Falls

Allison Inserro
A large meta-analysis did not find any beneficial effects to vitamin D supplementation for reducing fractures, falls, and bone mineral density, according to a recent study published in The Lancet Diabetes and Endocrinology.
Six-Year Study of Zoledronate for Osteopenia Shows Reduction in Fragility Fractures
October 10th 2018

Six-Year Study of Zoledronate for Osteopenia Shows Reduction in Fragility Fractures

Allison Inserro
Giving zoledronate every 18 months for 6 years reduced the risk of fragility fractures—both vertebral and nonvertebral—in older women with hip bone mineral density indicating osteopenia, a recent study published in The New England Journal of Medicine reported.
ASBMR's Updated Osteoporosis Guidelines Emphasize Communication to Avoid Secondary Fractures
October 8th 2018

ASBMR's Updated Osteoporosis Guidelines Emphasize Communication to Avoid Secondary Fractures

David Bai, PharmD
The decline in fractures caused by osteoporosis has stagnated, leading bone experts to suspect a lack in osteoporosis diagnosis and treatment guideline adherence. To combat this, the American Society for Bone and Mineral Research (ASBMR) has added 5 clinical care recommendations to prevent secondary fractures in at-risk patients.
Men at 3 Times Higher Risk of Secondary Fracture Within the First Year
October 5th 2018

Men at 3 Times Higher Risk of Secondary Fracture Within the First Year

Samantha DiGrande
Two studies presented at the American Society for Bone and Mineral Research 2018 Annual Meeting last month specifically addressed men’s bone health and compared their risks with those of women.
Study Compares Fracture Risks Between Osteoporosis, Osteopenia
September 26th 2018

Study Compares Fracture Risks Between Osteoporosis, Osteopenia

Alison Rodriguez
A recent study compared the fracture risk between osteoporosis and osteopenia.
Statin Use Cut Risk of Osteoporosis, Fractures, Study Finds
September 25th 2018

Statin Use Cut Risk of Osteoporosis, Fractures, Study Finds

Allison Inserro
A recent study found that statin use reduced the risks of osteoporosis, hip fracture, and vertebral fracture in stroke patients by 30% to 40%, and a dose-effect relationship was observed between statin cumulative defined daily doses and decreased risks of osteoporosis and fractures.
Researchers Struggle to Define Quality Indicators for Hip Fracture
September 22nd 2018

Researchers Struggle to Define Quality Indicators for Hip Fracture

Allison Inserro
Hip fractures (HF) are one of the most common injuries seen in emergency departments among the elderly, but quality care measures for hip fractures are lacking. To that end, a recent report sought to identify optimal quality indicators (QI) for clinical use, but researchers found gaps that need to be addressed.
<12345>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo